Cargando…
Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families
It was hypothesized that variants in underexplored homologous recombination repair (HR) genes could explain unsolved multiple-case breast cancer (BC) families. We investigated HR deficiency (HRD)-associated mutational signatures and second hits in tumor DNA from familial BC cases. No candidates gene...
Autores principales: | Matis, Thibaut S., Zayed, Nadia, Labraki, Bouchra, de Ladurantaye, Manon, Matis, Théophane A., Camacho Valenzuela, José, Hamel, Nancy, Atayan, Adrienne, Rivera, Barbara, Tabach, Yuval, Tonin, Patricia N., Orthwein, Alexandre, Mes-Masson, Anne-Marie, El Haffaf, Zaki, Foulkes, William D., Polak, Paz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387362/ https://www.ncbi.nlm.nih.gov/pubmed/34433815 http://dx.doi.org/10.1038/s41523-021-00315-8 |
Ejemplares similares
-
Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
por: Behl, Supriya, et al.
Publicado: (2020) -
Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants
por: Alenezi, Wejdan M., et al.
Publicado: (2022) -
BMP-2 signaling in ovarian cancer and its association with poor prognosis
por: Le Page, Cécile, et al.
Publicado: (2009) -
Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity
por: Wojnarowicz, P, et al.
Publicado: (2012) -
The Great Majority of Homologous Recombination Repair-Deficient Tumors Are Accounted for by Established Causes
por: Štancl, Paula, et al.
Publicado: (2022)